T1	Intervention 0 121	Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression
T2	Intervention 254 307	Zoledronic acid (ZOL) plus adjuvant endocrine therapy
T3	Intervention 764 947	patients received goserelin (3.6 mg every 28 days) and were randomized to tamoxifen (20 mg/days) or anastrozole (1 mg/days), both with or without ZOL (4 mg every 6 months) for 3 years
T4	Intervention 1872 1888	twice-yearly ZOL
